The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 26, 2023

Filed:

Jul. 27, 2019
Applicant:

Serina Therapeutics, Inc., Huntsville, AL (US);

Inventors:

Michael Bentley, Huntsville, AL (US);

Zhihao Fang, Madison, AL (US);

Rebecca Weimer, Huntsville, AL (US);

Tacey Viegas, Madison, AL (US);

Randall Moreadith, Huntsville, AL (US);

Assignee:

Serina Therapeutics, Inc., Huntsville, AL (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/485 (2006.01); A61K 47/59 (2017.01); A61K 9/00 (2006.01); A61K 31/05 (2006.01); A61K 31/12 (2006.01); A61K 31/137 (2006.01); A61K 31/15 (2006.01); A61K 31/198 (2006.01); A61K 31/24 (2006.01); A61K 31/277 (2006.01); A61K 31/36 (2006.01); A61K 31/55 (2006.01); A61K 47/14 (2017.01); A61K 47/18 (2017.01); A61K 47/20 (2006.01); A61K 47/22 (2006.01);
U.S. Cl.
CPC ...
A61K 31/485 (2013.01); A61K 9/0019 (2013.01); A61K 31/05 (2013.01); A61K 31/12 (2013.01); A61K 31/137 (2013.01); A61K 31/15 (2013.01); A61K 31/198 (2013.01); A61K 31/24 (2013.01); A61K 31/277 (2013.01); A61K 31/36 (2013.01); A61K 31/55 (2013.01); A61K 47/14 (2013.01); A61K 47/18 (2013.01); A61K 47/20 (2013.01); A61K 47/22 (2013.01); A61K 47/59 (2017.08); A61K 47/595 (2017.08);
Abstract

Described are conjugates comprising a water-soluble polymer linked to a compound comprising a catechol moiety via a cleavable linkage, wherein the cleavable linkage is formed between the water-soluble polymer and a first phenolic hydroxyl group of the catechol moiety and a second phenolic hydroxyl group of the catechol moiety is linked to a blocking group wherein the rate of hydrolytic release of the compound comprising the catechol moiety is controlled, at least in part, through structure or design of the blocking group on the second phenolic hydroxyl group of the catechol moiety. Therefore, the rate of hydrolytic release of the compound comprising the catechol moiety can be tuned through structural design of the group on the second phenolic hydroxyl group of the catechol moiety. Compounds used in the synthesis of the described conjugates and methods of using the described conjugate and other compounds in the treatment of dopamine-responsive disorders are also described.


Find Patent Forward Citations

Loading…